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Case report
Recurrent apparent life-threatening event as the first manifestation 
of congenital myasthenia
Evento com aparente risco de morte recorrente como manifestação inicial de síndrome miastênica congênita
Evento con aparente riesgo de muerte recurrente como manifestación inicial de síndrome miasténico congénito
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ABSTRACT
Objective: To alert pediatricians about the importance of 
a careful investigation on recurrent apparent life-threatening 
events. Reports of the association of these events with con-
genital myasthenic syndromes were not found.
Case description: A seven-month-old infant with re-
current apparent life-threatening events was admitted for 
investigation. During hospital stay, she presented cyanosis 
and respiratory failure, requiring mechanical ventilation for 
three days. After clinical improvement, hypotheses of gas-
troesophageal reflux and pulmonary aspiration were ruled 
out. The presence of eyelid ptosis, general hypotonia and 
weak crying led to the suspicion of congenital myasthenia, 
which was confirmed. Treatment with oral piridostigmine 
led to neurological and nutritional normalization, without 
any other apparent life-threatening event during the next 
three years.
Comments: The careful etiological investigation of 
apparent life-threatening events may lead to rare diagno-
sis that requires specific treatments, such as congenital 
myasthenia.
Key-words: infantile apparent life-threatening event; 
myasthenia gravis; muscle hypotonia; apnea; infant.
RESUMO
Objetivo: Alertar os pediatras sobre a necessidade de in-
vestigar criteriosamente a etiologia de eventos com aparente 
risco de morte recorrente. Não foram encontrados relatos 
associando tais eventos à miastenia congênita.
Descrição do caso: Lactente de sete meses apresentando his-
tória de eventos com aparente risco de morte recorrente foi inter-
nado para investigação. Durante a internação, apresentou cianose 
e dispneia progressiva, com necessidade de ventilação mecânica 
por três dias. Após a melhora clínica, e tendo sido descartadas as 
hipóteses de doença do refluxo gastroesofágico e aspiração pul-
monar como desencadeantes, notou-se ptose palpebral bilateral, 
hipotonia apendicular e choro fraco, que conduziram à suspeita 
clínica de miastenia congênita. Após confirmação do diagnóstico, 
foi mantido tratamento ambulatorial com piridostigmina, com 
recuperação nutricional e neurológica, sem novos eventos com 
aparente risco de morte nos três anos seguintes.
Comentários: A investigação minuciosa das causas de 
eventos com aparente risco de morte pode levar a diagnósticos 
menos frequentes que exigem tratamento específico, como 
a miastenia congênita.
Palavras-chave: evento com aparente risco de vida infan-
til; miastenia gravis; hipotonia muscular; apneia; lactente.
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RESUMEN
Objetivo: Alertar a los pediatras sobre la necesidad de 
investigar criteriosamente la etiología de eventos con apa-
rente riesgo de muerte recurrente. No se encontraron relatos 
asociando tales eventos a la miastenia congénita.
Descripción del caso: Lactante de siete meses presentando 
historia de eventos con aparente riesgo de muerte recurrente 
fue internado para investigación. Durante la internación, pre-
sentó cianosis y disnea progresiva, con necesidad de ventilación 
mecánica por tres días. Después de la mejora clínica, y ha-
biendo sido rechazadas las hipótesis de enfermedad del reflujo 
gastroesofágico y aspiración pulmonar como desencadenantes, 
se notó ptosis palpebral bilateral, hipotonía apendicular y 
lloro débil, que condujeron a la sospecha clínica de miastenia 
congénita. Después de la confirmación del diagnóstico, se 
mantuvo el tratamiento ambulatorial con piridostigmina, con 
recuperación nutricional y neurológica, sin nuevos eventos con 
aparente riesgo de muerte en los tres años siguientes.
Comentarios: La investigación minuciosa de las causas de 
eventos con aparente riesgo de muerte puede llevar a diag-
nósticos menos frecuentes que exigen tratamiento específico, 
como la miastenia congénita.
Palabras clave: evento con aparente riesgo de vida infan-
til; miastenia gravis; hipotonía muscular; apnea; lactante.
Introduction
Apparent life-threatening events (ALTE) are defined as 
frightening episodes to the observer, characterized by a 
combination of apnea (central or obstructive), change in 
skin color (cyanotic or pallid), change in the muscle tone 
(hypotonia), choke, or gag reflex(1,2). 
The occurrence of an ALTE in healthy infants is not an infre-
quent fact, usually as a single event, with short time duration 
and with complete and spontaneous resolution(2,3). However, 
although most of the events have no pathological meaning and 
have benign course, the ALTE may be associated with a variety 
of underlying diseases(2-10). Some infants exhibit recurrence of the 
signs and symptoms of ALTE, with progressively more severe 
clinical presentation compared to the initial event, which raises the 
risk of subsequent morbidity and mortality associated with the 
event itself or with the disease that caused it(3-9). 
This report aimed to describe the case of an infant suffering 
from congenital myasthenic syndrome who had recurrent episodes 
of ALTE as the initial manifestation of the disease. The publica-
tion of these data was approved by the Research Ethics Committee 
of the Faculty of Medical Sciences/UNICAMP (144/2011). 
Case report
A seven-month-old female infant was referred for in-
vestigation of recurrent episodes of ALTE. She was a full 
term infant with adequate weight for gestational age (birth 
weight: 3,260g), and Apgar scores of 8 and 9, in the 1st and 
5th minutes. The patient received exclusive breastfeeding 
during the first month of life and infant formula from the 
second, with poor weight gain. In the third month, she had 
daily episodes of ALTE – cyanosis associated with nausea 
and vomiting. Esophagus, stomach and duodenum contrast 
examination were conducted, which showed aspiration by 
the presence of contrast in the bronchial tree. The video-
fluoroscopy showed swallowing disorder, with completion 
by the contrast of the hypo and nasopharynx, as well as the 
larynx, with several episodes of aspiration of contrast. Since 
then, she received exclusive nasogastric tube feeding associ-
ated with postural anti-reflux therapy and prokinetic drugs 
(ranitidine, domperidone and erythromycin). At the age of 5 
months, the infant had a new episode of ALTE, characterized 
by pallor followed by cyanosis, that occurred with elevated 
head during the exchange of a nasogastric tube, requiring 
mechanical ventilation for 3 days. Aspirative pneumonia 
was diagnosed as the cause of the event. 
At 7 months, in the first outpatient visit at this service, the 
infant was admitted for investigation. After 12 hours of admis-
sion, there was a new episode of ALTE in supine position during 
venipuncture procedure, characterized by generalized cyanosis 
and progressive respiratory distress, coursing with apnea and 
need of mechanical ventilation for 3 days. In this period there 
was no evidence of any signs of aspiration pneumonia. The 
results of high endoscopy and skull computed tomography 
showed no esophagogastric or encephalic anatomical abnor-
malities. The following blood tests were performed: serum free 
thyroxine (T4): 1.09ng/dL (0.9 to 1.8), Thyroid-stimulating 
hormone (TSH): 1.20UUI/mL (0.41 to 4.5), creatine kinase 
(CK): 62U/L (<145), lactate: 1.0mmol /L (0.5 to 1.6) and lactate 
dehydrogenase (LDH): 734U/L (<1,100).
After discharge from the Pediatric Intensive Care Unit, 
still during hospitalization at the Pediatric Ward, the follow-
ing symptoms were noticed: bilateral and floating mild eyelid 
ptosis, constant weak cry, and mild appendicular hypotonia, 
so then the hypothesis of congenital myasthenic syndrome 
was considered. Thus, a therapeutic trial with pyridostigmine was 
conducted, which resulted in eye opening, strong cry, and overall 
muscle tone improvement in few seconds, characterizing posi-
tive response to the trial. The EMG examination performed 
later showed neuromuscular junction dysfunction, which 
confirmed the diagnosis of congenital myasthenic syndrome, 
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so a continuous treatment with pyridostigmine was conducted. 
After adjusting the dosage of medication, it was possible to 
reassume oral feeding, with removal of nasogastric tube and 
without recurrence of ALTE since then.
Currently, the child is receiving outpatient treatment for 
over 3 years, with good weight gain and neuropsychomotor 
development progression to normality in continuous use of 
pyridostigmine.
Discussion
No other case reporting association between ALTE and 
congenital myasthenic syndrome were found in the analyzed 
literature, regardless of the known fact that the initial presen-
tation of the myasthenic syndrome may course with as eating 
disorders, leading to apnea, often attributed to gastroesophageal 
reflux disease (11). Although the patient had had frequent medical 
follow-up from birth, especially after the onset of symptoms, the 
clinical suspicion of congenital myasthenic syndrome occurred 
only at the age of 7 months, when the eyelid ptosis, the weak 
cry, and the appendicular hypotonia became apparent.
This syndrome is a rare and chronic disease, characterized 
by rapid fatigue of the striated skeletal muscles, especially 
the extrinsic ocular, swallowing, phonation, and respiratory 
muscles, as in the case described(12,13). The most frequent 
cause is immune-mediated blockage of the neuromuscular 
junction, i.e., the release of acetylcholine in the synaptic cleft 
is normal, however, the postsynaptic membrane responds 
unsatisfactorily to the stimulus(11-15). 
In young infants, as in the described case, the main clini-
cal manifestation of myasthenia is feeding difficulty(11,12,14). 
Cervical hypotonia and poor control of head movement are 
also common, as well as appendicular muscle hypotonia(11,12,14). 
The eyelid ptosis is uncommon in young infants(11,12). Episodic 
apnea and swallowing difficulty are common in infants with 
congenital myasthenic syndrome, which explains the numer-
ous episodes of ALTE described in this case report(11-13). 
Electromyography, which is the indicated test for confirm-
ing the clinical suspicion, showed decrease in the pattern of 
response to repetitive muscle stimulation, with reduction 
in the amplitude of the waves, culminating in the absence 
of response to stimuli. This pattern is reversible by the 
use of cholinesterase inhibitors(12,14). Although the test can 
be inconclusive in infants, when positive it supports the 
diagnosis, as in the case described(12,14,15). Serum antibodies 
anticholinesterase measurements can be performed, and high 
results confirm the diagnosis. However, a negative result 
does not exclude the diagnosis, since changes in infants with 
congenital myasthenic syndrome are rarely found(11,14). This 
test was not performed in the patient described.
A therapeutic trial with short-acting cholinesterase in-
hibitors (prostigmine methylsulfate) is recommended for 
diagnosis confirmation(11,13). The positive response is a rapid 
and fleeting improvement of ptosis, ocular plegia, and speech 
muscles, as seen in the present case report(11,13). Maintenance 
treatment must be performed with cholinesterase inhibitors 
of long duration, such as pyridostigmine(11-14). 
The authors are aware of the rarity of congenital myas-
thenic syndrome diagnosis. Therefore, this should not be 
considered as the most likely diagnosis for infants with 
ALTE; however, it cannot be discharged when clinic and evo-
lution are compatible, especially with severe and recurrent 
events, after the most frequent etiologies have been excluded, 
such as esophageal reflux disease and respiratory diseases. 
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